May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
A2E Accumulation Associated with Elovl4 and Macular Degeneration
Author Affiliations & Notes
  • D.J. Cameron
    Chemistry and Biochemistry, Brigham Young University, Provo, UT
  • G. Karan
    Department of Ophthalmology and Visual Science, and Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT
  • Z. Yang
    Department of Ophthalmology and Visual Science, and Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT
  • X. Li
    Department of Ophthalmology and Visual Science, and Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT
  • K. Zhang
    Department of Ophthalmology and Visual Science, and Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT
  • H.R. Vollmer–Snarr
    Chemistry and Biochemistry, Brigham Young University, Provo, UT
  • Footnotes
    Commercial Relationships  D.J. Cameron, None; G. Karan, None; Z. Yang, None; X. Li, None; K. Zhang, None; H.R. Vollmer–Snarr, None.
  • Footnotes
    Support  NIH Grants RO1 EY14448 and EY14438, the Steinbach Fund, and the Macular Vision Research Foundation
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1767. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.J. Cameron, G. Karan, Z. Yang, X. Li, K. Zhang, H.R. Vollmer–Snarr; A2E Accumulation Associated with Elovl4 and Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1767.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Stargardt–like macular dystrophy is an autosomal dominant form of early onset macular degeneration. The disease causing gene ELOVL4 encodes a protein that belongs to a family of proteins functioning in elongation of long chain fatty acids. The purpose of this study is to investigate the A2E accumulation in mouse eyes with human mutant ELOVL4 transgene, a model of Stargardt–like macular dystrophy and age–related macular degeneration. Methods:Mice with human mutant ELOVL4 transgene are raised under normal breeding conditions. The retinas are removed from mice at 4–7 months of age and from mice 8–11 months in age. The eye cups (RPE) are separated from the retinas. A2E is extracted from the RPE samples and quantified using reverse phase high pressure liquid chromatography (HPLC). Results: A2E was found in the RPE of mutant ELOVL4 transgenic mice. Quantification of A2E revealed that approximately 0.83 nanomoles of A2E per eye was present in transgenic mice at age ranges 6–11 months. Conclusions: The identified levels of A2E suggest that Elovl4 may play a role in A2E accumulation and suggest RPE toxicity may be a mechanism of macular degeneration.

Keywords: age–related macular degeneration • macular pigment • transgenics/knock–outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×